Quanterix (QTRX) Operating Margin Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 241.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 535.00 |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn | -2,666.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,666.00 |
| Dec 31, 2025 | -1,443.00 |
| Sep 30, 2025 | -5,997.00 |
| Jun 30, 2025 | -11,975.00 |
| Mar 31, 2025 | -3,965.00 |
| Dec 31, 2024 | 116.00 |
| Sep 30, 2024 | 778.00 |
| Jun 30, 2024 | -265.00 |
| Mar 31, 2024 | -1,009.00 |
| Dec 31, 2023 | 3,968.00 |
| Sep 30, 2023 | 10,186.00 |
| Jun 30, 2023 | 8,556.00 |
| Mar 31, 2023 | 2,358.00 |
| Dec 31, 2022 | -2,396.00 |
| Sep 30, 2022 | -8,743.00 |
| Jun 30, 2022 | -6,086.00 |
| Mar 31, 2022 | -2,478.00 |
| Dec 31, 2021 | -2,086.00 |
| Sep 30, 2021 | -6,227.00 |
| Jun 30, 2021 | 3,905.00 |
| Mar 31, 2021 | 3,860.00 |
| Dec 31, 2020 | 3,415.00 |
| Sep 30, 2020 | 7,580.00 |
| Jun 30, 2020 | -1,525.00 |
| Mar 31, 2020 | 127.00 |
| Dec 31, 2019 | 1,439.00 |
| Sep 30, 2019 | 380.00 |
| Jun 30, 2019 | 691.00 |
| Mar 31, 2019 | 1,939.00 |
| Dec 31, 2018 | 2,110.00 |
| Sep 30, 2018 | 3,904.00 |
| Jun 30, 2018 | 3,950.00 |
| Mar 31, 2018 | 1,821.00 |